Literature DB >> 31273053

Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.

Chun-I Wang1, Huang-Kai Kao2,3, Ting-Wen Chen4,5,6, Yenlin Huang7, Hsing-Wen Cheng8, Jui-Shan Yi8,9, Shao-Yu Hung2, Chi-Sheng Wu8,9, Yun-Shien Lee10, Kai-Ping Chang1,3,9.   

Abstract

BACKGROUND: DNA copy number variations (CNVs) are a hallmark of cancer, and the current study aimed to demonstrate the profile of the CNVs for oral cavity squamous cell carcinoma (OSCC) and elucidate the clinicopathological associations and molecular mechanisms of a potential marker derived from CNVs, mixed-lineage leukemia translocated to chromosome 3 protein (MLLT3), in OSCC carcinogenesis.
MATERIALS AND METHODS: CNVs in 37 OSCC tissue specimens were analyzed using a high-resolution microarray, the OncoScan array. Gene expression was analyzed by real-time polymerase chain reaction in 127 OSCC and normal tissue samples. Cell function assays included cell cycle, migration, invasion and chromatin immunoprecipitation assays.
RESULTS: We found a novel copy number amplified region, chromosome 9p, encompassing MLLT3 via the comparison of our data set with six other OSCC genome-wide CNV data sets. MLLT3 overexpression was associated with poorer overall survival in patients with OSCC (p = .048). MLLT3 knockdown reduced cell migration and invasion. The reduced invasion ability in MLLT3-knockdown cells was rescued with double knockdown of MLLT3 and CBP/p300-interacting transactivator with ED rich carboxy-terminal domain 4 (CITED4; 21.0% vs. 61.5%). Knockdown of MLLT3 impaired disruptor of telomeric silencing-1-like (Dot1L)-associated hypermethylation in the promoter of the tumor suppressor, CITED4 (p < .001), and hence dysregulated HIF-1α-mediated genes (TWIST, MMP1, MMP2, VIM, and CDH1) in OSCC cells.
CONCLUSION: We identified unique CNVs in tumors of Taiwanese patients with OSCC. Notably, MLLT3 overexpression is related to the poorer prognosis of patients with OSCC and is required for Dot1L-mediated transcriptional repression of CITED4, leading to dysregulation of HIF-1α-mediated genes. IMPLICATIONS FOR PRACTICE: This article reports unique copy number variations in oral cavity squamous cell carcinoma (OSCC) tumors of Taiwanese patients. Notably, MLLT3 overexpression is related to the poorer prognosis of patients with OSCC and is required for Dot1L-mediated transcriptional repression of CITED4, leading to dysregulation of HIF-1α-mediated genes. © AlphaMed Press 2019.

Entities:  

Keywords:  CITED4; Copy number variations; HIF‐1α; MLLT3; Oral cavity squamous cell carcinoma

Year:  2019        PMID: 31273053      PMCID: PMC6975970          DOI: 10.1634/theoncologist.2019-0063

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  78 in total

1.  Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.

Authors:  Chi-Chen Fan; Tao-Yeuan Wang; Yen-An Cheng; Shih Sheng Jiang; Chien-Wen Cheng; Alan Yueh-Luen Lee; Ting-Yu Kao
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

2.  Genetic progression model for head and neck cancer: implications for field cancerization.

Authors:  J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  Proteogenomic characterization of human colon and rectal cancer.

Authors:  Bing Zhang; Jing Wang; Xiaojing Wang; Jing Zhu; Qi Liu; Zhiao Shi; Matthew C Chambers; Lisa J Zimmerman; Kent F Shaddox; Sangtae Kim; Sherri R Davies; Sean Wang; Pei Wang; Christopher R Kinsinger; Robert C Rivers; Henry Rodriguez; R Reid Townsend; Matthew J C Ellis; Steven A Carr; David L Tabb; Robert J Coffey; Robbert J C Slebos; Daniel C Liebler
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

4.  hDOT1L links histone methylation to leukemogenesis.

Authors:  Yuki Okada; Qin Feng; Yihui Lin; Qi Jiang; Yaqiang Li; Vernon M Coffield; Lishan Su; Guoliang Xu; Yi Zhang
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

5.  Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.

Authors:  Jian-Feng Liu; Wei-Wei Deng; Lei Chen; Yi-Cun Li; Lei Wu; Si-Rui Ma; Wen-Feng Zhang; Lin-Lin Bu; Zhi-Jun Sun
Journal:  Mol Carcinog       Date:  2017-12-30       Impact factor: 4.784

6.  Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.

Authors:  Chun-I Wang; Chia-Jung Yu; Yenlin Huang; Jui-Shan Yi; Hsing-Wen Cheng; Huang-Kai Kao; William Wei-Kai Lao; Kai-Ping Chang
Journal:  Head Neck       Date:  2018-03-15       Impact factor: 3.147

7.  Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.

Authors:  Weili Chen; Ashish R Kumar; Wendy A Hudson; Quanzhi Li; Baolin Wu; Rodney A Staggs; Erik A Lund; Thien N Sam; John H Kersey
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

8.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

Authors:  Andrei V Krivtsov; Zhaohui Feng; Madeleine E Lemieux; Joerg Faber; Sridhar Vempati; Amit U Sinha; Xiaobo Xia; Jonathan Jesneck; Adrian P Bracken; Lewis B Silverman; Jeffery L Kutok; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.

Authors:  Joseph M Foster; Assa Oumie; Fiona S Togneri; Fabiana Ramos Vasques; Debra Hau; Morag Taylor; Emma Tinkler-Hundal; Katie Southward; Paul Medlow; Keith McGreeghan-Crosby; Iris Halfpenny; Dominic J McMullan; Phil Quirke; Katherine E Keating; Mike Griffiths; Karen G Spink; Fiona Brew
Journal:  BMC Med Genomics       Date:  2015-02-18       Impact factor: 3.063

10.  Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.

Authors:  Yink Heay Kong; Sharifah Nurain Syed Zanaruddin; Shin Hin Lau; Anand Ramanathan; Thomas George Kallarakkal; Vui King Vincent-Chong; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Zainal Ariff Abdul Rahman; Rosnah Binti Zain; Sok Ching Cheong
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more
  2 in total

Review 1.  Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors.

Authors:  Elena Alexandrova; Annamaria Salvati; Giovanni Pecoraro; Jessica Lamberti; Viola Melone; Assunta Sellitto; Francesca Rizzo; Giorgio Giurato; Roberta Tarallo; Giovanni Nassa; Alessandro Weisz
Journal:  Front Genet       Date:  2022-04-13       Impact factor: 4.772

2.  Survival-related genes are diversified across cancers but generally enriched in cancer hallmark pathways.

Authors:  Po-Wen Wang; Yi-Hsun Su; Po-Hao Chou; Ming-Yueh Huang; Ting-Wen Chen
Journal:  BMC Genomics       Date:  2022-05-04       Impact factor: 4.547

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.